Glycan Sequencing via Lectin Microarrays and ML
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current glycan measurement techniques are labor-intensive, time-consuming, and lack the ability to easily sequence complex glycans, and accurately compare glycoprofiles, hindering their application in clinical diagnostics and therapeutic strategies.
Innovation Solution
The development of GLY-Seq Diagnostics (GSD) method, which involves glycan substructure analysis using a two-step process: quantifying glyco-motif profiles and applying a classifier to classify samples, enabling easier translation of glycan changes into clinical strategies through glycan sequencing and machine learning approaches.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If mass spectrometry is used for glycan analysis, then measurement precision is improved, but productivity deteriorates due to time-consuming and laborious procedures
Solution Approach 1:
The patent uses lectins as intermediary molecules that specifically bind to glycans, serving as a bridge between the sample and detection system. This allows glycan profiling through lectin binding patterns rather than direct mass spectrometry, maintaining structural information while simplifying the workflow and increasing throughput
Solution Approach 2:
The patent creates a computational model that copies and reconstructs mass spectrometry-based glycan profiles from simpler lectin microarray data. This computational copying allows the benefits of MS-level precision to be achieved through lower-throughput lectin-based methods, effectively decoupling precision from productivity constraints
2Productivity
If lectin microarray is used for glycan analysis, then productivity is improved through high throughput, but measurement precision deteriorates due to inability to provide precise structural information
Solution Approach 1:
The patent introduces computational algorithms as an intermediary layer that processes lectin binding patterns and translates them into detailed glycan structural information. This computational mediation allows the system to achieve MS-level structural precision while maintaining the high throughput advantages of lectin microarrays
Solution Approach 2:
The patent creates a computational reconstruction of mass spectrometry glycan profiles from lectin microarray data. By copying the essential structural information through computational modeling rather than direct measurement, the system achieves high precision without sacrificing throughput
3Measurement precision
If traditional glycan measurement techniques are used, then measurement precision is improved, but ease of operation deteriorates due to difficult protocols requiring extensive hands-on time and experience
Solution Approach 1:
The patent implements automated computational pipelines that perform glycan profile reconstruction and analysis without requiring manual intervention. The system serves itself by automatically processing raw lectin microarray data through computational algorithms to generate clinically actionable glycan profiles, eliminating the need for extensive hands-on experience
Solution Approach 2:
The patent replaces complex manual mechanical procedures (glycan release, purification, enzymatic digestions) with computational processing of lectin binding data. This substitution of mechanical operations with information processing dramatically simplifies the workflow while maintaining measurement precision
4Measurement precision
If glycoprofiles are compared using traditional methods, then measurement precision is improved, but productivity deteriorates due to difficulty in comparing datasets with size, sparsity, heterogeneity and interdependence
Solution Approach 1:
The patent segments the complex glycoprofile comparison task into manageable computational steps: data normalization, feature selection, and hierarchical clustering. This segmentation allows efficient processing of large, sparse, heterogeneous datasets while maintaining the precision of individual glycan measurements
Solution Approach 2:
The patent creates simplified computational representations (copies) of complex glycoprofiles that retain essential comparative information. These compressed representations enable rapid comparison across large datasets without sacrificing the precision needed for clinical diagnostics
Data Source
AI summary
Method for using glycan or glycomics data for classification, diagnosis, prognosis, subject stratification, or therapy decision making based on a sample with glycans or glycosylated molecules.